Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.
Neuro Oncol. 2024 Mar 20:noae060. doi: 10.1093/neuonc/noae060. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38507464
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283.
Pelaz SG, Jaraíz-Rodríguez M, Álvarez-Vázquez A, Talaverón R, García-Vicente L, Flores-Hernández R, Gómez de Cedrón M, Tabernero M, Ramírez de Molina A, Lillo C, Medina JM, Tabernero A.
Pelaz SG, et al. Among authors: alvarez vazquez a.
EBioMedicine. 2020 Dec;62:103134. doi: 10.1016/j.ebiom.2020.103134. Epub 2020 Nov 27.
EBioMedicine. 2020.
PMID: 33254027
Free PMC article.
Item in Clipboard
Erratum to "Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283" [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134.
Pelaz SG, Jaraíz-Rodríguez M, Álvarez-Vázquez A, Talaverón R, García-Vicente L, Flores-Hernández R, de Cedrón MG, Tabernero M, de Molina AR, Lillo C, Medina JM, Tabernero A.
Pelaz SG, et al. Among authors: alvarez vazquez a.
EBioMedicine. 2021 Dec;74:103752. doi: 10.1016/j.ebiom.2021.103752. Epub 2021 Dec 12.
EBioMedicine. 2021.
PMID: 34911027
Free PMC article.
No abstract available.
Item in Clipboard
Erratum to 'Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo'.
Jaraíz-Rodríguez M, Talaverón R, García-Vicente L, Pelaz SG, Domínguez-Prieto M, Álvarez-Vázquez A, Flores-Hernández R, Sin WC, Bechberger J, Medina JM, Naus CC, Tabernero A.
Jaraíz-Rodríguez M, et al. Among authors: alvarez vazquez a.
Neuro Oncol. 2021 Aug 2;23(8):1414. doi: 10.1093/neuonc/noaa087.
Neuro Oncol. 2021.
PMID: 32515482
Free PMC article.
No abstract available.
Item in Clipboard
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.
Jaraíz-Rodríguez M, Talaverón R, García-Vicente L, Pelaz SG, Domínguez-Prieto M, Álvarez-Vázquez A, Flores-Hernández R, Sin WC, Bechberger J, Medina JM, Naus CC, Tabernero A.
Jaraíz-Rodríguez M, et al. Among authors: alvarez vazquez a.
Neuro Oncol. 2020 Apr 15;22(4):493-504. doi: 10.1093/neuonc/noz243.
Neuro Oncol. 2020.
PMID: 31883012
Free PMC article.
Item in Clipboard
Cite
Cite